6th North American ABC workshop Conference

date

2009

related documents

Lapatinib, erlotinib, imatinib and nilotinib are potent reversal agents for MRP7 (ABCC10)-mediated multidrug resistance Conference Poster (Faculty180)
Nilotinib (AMN107, Tasigna) reverses multidrug resistance by inhibiting the activity of the ABCB1/Pgp and ABCG2/BCRP/MXR transporters Conference Poster (Faculty180)

event location

NCI, NIH, Bethesda, MD